登革热狂热症成功地用CytoSorb®与连续脏替代疗法结合使用血液输血治疗:一个病例报告
Piyum Samarasingha1, Harindra Karunatilake2, Ananda Jayanaga2
1National Hospital of Sri Lanka, Colombo, Sri Lanka. piyumsamarasingha91@gmail.com.
Journal of medical case reports
|July 18, 2024
概括
登革热可以导致严重的狂犬病和急性损伤. 在一个罕见的案例中,当 CytoSorb® 吸附剂被添加到连续的毒性血液过中以控制高水平的肌酸酶和肌球蛋白时,它改善了结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 登革热呈现出各种临床表现,包括扩大登革热综合征.
- 导致急性损伤的狂犬病导致急性损伤是登革热感染的一种罕见但严重的并发症.
- 在登革热中拉布多米解的病理生理学仍然不完全理解.
相关概念视频
Dialysis
288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
Heart Failure Drugs: Diuretics
361
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
361
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418


